A Benign Biopsy Result Does Not End the Melanoma Workup

A benign pathology report from a partial biopsy can miss melanoma sitting centimeters away in the same lesion — a point Kate Gerber, MD, presses in a recent Medscape commentary for clinicians managing pigmented lesions.

Gerber, associate faculty in dermatology at HCA Florida Blake Hospital in Bradenton, Florida, and associate professor at Florida State College of Medicine in Sarasota, frames the problem in concrete dimensional terms. A 2-cm irregular, pigmented lesion sampled with a 3-mm punch from one edge can return a report of a normal benign nevus while melanoma persists elsewhere in the lesion. The pathology describes only the tissue removed, not the lesion as a whole.

Her instruction is direct: if clinical suspicion for melanoma remains high, bring the patient back for re-biopsy or resampling. A benign result never overrides clinical context.

What should trigger continued evaluation despite benign histology?

Several clinical features justify ongoing melanoma evaluation even after a benign report, according to the guidance accompanying the piece:

• Evolution of the lesion over time
• Asymmetry
• Irregular borders
• Color variation
• Ulceration or bleeding
• A lesion that looks more concerning clinically than the biopsy suggests

Clinical judgment remains central, the guidance notes, because a partial biopsy can miss the most malignant component of a heterogeneous lesion. Heterogeneity is the core hazard: the diagnostic area and the sampled area may not overlap at all.

Which biopsy techniques reduce sampling error?

Sampling error is minimized by selecting the most atypical portion of the lesion and using a technique that captures sufficient depth and breadth for diagnosis. For larger, irregular, or heterogeneous pigmented lesions, partial biopsies can miss the most diagnostic area. In those cases, clinicians often move toward broader sampling or excisional biopsy when feasible — the technique that removes the entire lesion for histologic review.

The tradeoff is practical. Excisional biopsy demands more time, tissue and planning, yet it eliminates the failure mode Gerber describes: a punch that reads benign while the true melanoma sits outside the specimen.

When does dermatopathology deserve a second look?

A second-opinion dermatopathology review is commonly useful in three situations: histology is unexpected, the lesion is clinically worrisome, or the initial specimen is limited. Re-review can reconcile subtle melanocytic atypia (mild-to-moderate atypical features in pigment cells that may not clearly cross the threshold for melanoma), margin issues, and sampling limitations. It may change management when the pathology report does not fit the clinical picture.

Gerber's advice on discordance is procedural rather than abstract. When the clinical impression and the histology do not align, clinicians should reassess whether the biopsy adequately sampled the most abnormal area. The common sequence is direct discussion with the dermatopathologist, slide review, and repeat biopsy if concern persists.

The key principle, as the guidance states it: pathology must be interpreted in the context of the full lesion.

What is the management pathway after a benign result?

A benign biopsy does not exclude melanoma when the sampled tissue may not represent the entire lesion. Continued evaluation is driven by the lesion's clinical appearance, growth pattern, asymmetry, color variegation, border irregularity, and overall level of suspicion. When concern remains high, repeat sampling or complete excision is the usual next diagnostic step.

The piece closes on a systemic note rather than a technical one. Every pathology report answers a question about a specimen, not about a patient. The clinician, not the report, decides whether the specimen represented the disease — and as partial sampling of large lesions remains routine, that gap between what was removed and what remains will keep demanding re-biopsy, dermatopathologist consultation, and, where suspicion warrants, complete excision.